Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 922

1.

Delivery of Niacinamide to the Skin Using Microneedle-Like Particles.

Shin CI, Kim M, Kim YC.

Pharmaceutics. 2019 Jul 11;11(7). pii: E326. doi: 10.3390/pharmaceutics11070326.

2.

Clinical and in vitro evaluation of new anti-redness cosmetic products in subjects with winter xerosis and sensitive skin.

Nisbet S, Targett D, Rawlings AV, Qian K, Wang X, Lin CB, Thompson MA, Bulsara PA, Moore DJ.

Int J Cosmet Sci. 2019 Jul 15. doi: 10.1111/ics.12559. [Epub ahead of print]

PMID:
31309600
3.

Niacinamide Protects Skin Cells from Oxidative Stress Induced by Particulate Matter.

Zhen AX, Piao MJ, Kang KA, Fernando PDSM, Kang HK, Koh YS, Yi JM, Hyun JW.

Biomol Ther (Seoul). 2019 Jul 5. doi: 10.4062/biomolther.2019.061. [Epub ahead of print]

4.

Depigmentation and anti-aging treatment by natural molecules.

Zaid A, Al Ramahi R.

Curr Pharm Des. 2019 Jul 3. doi: 10.2174/1381612825666190703153730. [Epub ahead of print]

PMID:
31269882
5.

Evolution of the use of antioxidants in anti-ageing cosmetics.

Silva S, Ferreira M, Oliveira AS, Magalhães C, Sousa ME, Pinto M, Sousa Lobo JM, Almeida IF.

Int J Cosmet Sci. 2019 Aug;41(4):378-386. doi: 10.1111/ics.12551.

PMID:
31220359
6.

DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.

Campuzano-García AE, Torres-Alvarez B, Hernández-Blanco D, Fuentes-Ahumada C, Cortés-García JD, Castanedo-Cázares JP.

Biomed Res Int. 2019 Apr 22;2019:9068314. doi: 10.1155/2019/9068314. eCollection 2019.

7.

Treatment of Arsenic-Induced Bowen’s Disease With Topical 5-Fluorouracil

Verhave B, Goldberg M, Hashim P, Levitt J.

J Drugs Dermatol. 2019 May 1;18(5):477-479.

PMID:
31141858
8.

Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation

Desai S, Ayres E, Bak H, Manco M, Lynch S, Raab S, Du A, Green D, Skobowiat C, Wangari-Talbot J, Zheng Q.

J Drugs Dermatol. 2019 May 1;18(5):454-459.

PMID:
31141852
9.

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.

Wang E, Xia D, Bai W, Yuan J, Li X, Niu J, Yin Z, Xia J, Cai H, Fan D, Han G, Liu L.

BMC Cancer. 2019 Apr 30;19(1):409. doi: 10.1186/s12885-019-5570-z.

10.

A comparative study on the effectiveness of herbal extracts vs 2.5% benzoyl peroxide in the treatment of mild to moderate acne vulgaris.

Lubtikulthum P, Kamanamool N, Udompataikul M.

J Cosmet Dermatol. 2019 Apr 23. doi: 10.1111/jocd.12962. [Epub ahead of print]

PMID:
31012999
11.

[Sustained Complete Response of Hepatocellular Carcinoma with Multiple Intrahepatic Metastases following the Discontinuation of Sorafenib].

Takeda Y, Ohmura Y, Katsura Y, Sakamoto T, Nose Y, Mori R, Inatome J, Kawai K, Naito A, Murakami K, Kagawa Y, Masuzawa T, Takeno A, Egawa C, Murata K.

Gan To Kagaku Ryoho. 2019 Mar;46(3):532-536. Japanese.

PMID:
30914605
12.

Sorafenib induces synergistic effect on inhibition of vemurafenib resistant melanoma growth.

Srivastava A, Moorthy A.

Front Biosci (Schol Ed). 2019 Mar 1;11:193-202.

PMID:
30844744
13.

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide.

Kildegaard J, Buckley ST, Nielsen RH, Povlsen GK, Seested T, Ribel U, Olsen HB, Ludvigsen S, Jeppesen CB, Refsgaard HHF, Bendtsen KM, Kristensen NR, Hostrup S, Sturis J.

Pharm Res. 2019 Feb 11;36(3):49. doi: 10.1007/s11095-019-2578-7.

14.

Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.

Snaidr VA, Damian DL, Halliday GM.

Exp Dermatol. 2019 Feb;28 Suppl 1:15-22. doi: 10.1111/exd.13819. Review.

PMID:
30698874
15.

Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.

Park J, Lee H, Lim GS, Kim N, Kim D, Kim YC.

AAPS PharmSciTech. 2019 Jan 29;20(3):96. doi: 10.1208/s12249-019-1309-z.

PMID:
30694397
16.

Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.

Lederhandler M, Beasley JM, Brinster NK, Nagler AR.

Dermatol Online J. 2018 Dec 15;24(12). pii: 13030/qt8b40k5kg.

17.

β-Hydroxy-β-methyl Butyrate/L-Arginine/L-Glutamine Supplementation for Preventing Hand-Foot Skin Reaction in Sorafenib for Advanced Hepatocellular Carcinoma.

Naganuma A, Hoshino T, Ohno N, Ogawa Y, Murakami T, Horiguchi S, Uehara D, Suzuki Y, Hatanaka T, Kudo T, Ishihara H, Sato K, Kakizaki S, Takagi H.

In Vivo. 2019 Jan-Feb;33(1):155-161. doi: 10.21873/invivo.11452.

18.

A comparison of the in vitro permeation of niacinamide in mammalian skin and in the Parallel Artificial Membrane Permeation Assay (PAMPA) model.

Zhang Y, Lane ME, Hadgraft J, Heinrich M, Chen T, Lian G, Sinko B.

Int J Pharm. 2019 Feb 10;556:142-149. doi: 10.1016/j.ijpharm.2018.11.065. Epub 2018 Dec 6.

PMID:
30529662
19.

Split-face Evaluation of a Multi-ingredient Brightening Foam Versus a Reference Control in Women with Photodamaged Facial Skin.

Stephens TJ, Babcock M, Bucay V, Gotz V.

J Clin Aesthet Dermatol. 2018 Oct;11(10):24-28. Epub 2018 Oct 1.

20.

3D-printed Franz type diffusion cells.

Sil BC, Alvarez MP, Zhang Y, Kung CP, Hossain M, Iliopoulos F, Luo L, Crowther JM, Moore DJ, Hadgraft J, Lane ME, Hilton ST.

Int J Cosmet Sci. 2018 Dec;40(6):604-609. doi: 10.1111/ics.12504.

PMID:
30468516

Supplemental Content

Loading ...
Support Center